Prescription stimulant prescribing, nonmedical use, and shortages: US FDA research and response
Fuente:
Wiley Open Access
Enregistré dans:
| Format: | Artículo Open Access |
|---|---|
| Publié: |
Wiley
2025
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Stimulant prescribing up among teens, but nonmedical use down
par: Alison Knopf
Publié: (2025)
par: Alison Knopf
Publié: (2025)
AACAP on advocating amidst stimulant shortage
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
Teens prescribed stimulants for ADHD not likely to have later drug misuse
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
FDA facing challenges: GAO
Publié: (2026)
Publié: (2026)
FDA lifts bans on fruit vapes
Publié: (2026)
Publié: (2026)
Research and clinical use of transcranial magnetic stimulation
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
FDA approves first genetic test to help identify risk of developing opioid use disorder
Publié: (2024)
Publié: (2024)
From the FDA: Nicotine pouches can be dangerous to children
Publié: (2025)
Publié: (2025)
Reorganizing the FDA is not a good idea: Former officials
Publié: (2025)
Publié: (2025)
FDA urges higher naloxone doses in fentanyl era
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
Treatments needed for young people with stimulant use disorders
par: Alison Knopf
Publié: (2025)
par: Alison Knopf
Publié: (2025)
Ob‐gyns respond to recent FDA discussion on SSRIs in pregnancy
par: Alison Knopf
Publié: (2025)
par: Alison Knopf
Publié: (2025)
FDA warns against ultra‐processed food risks to children
Publié: (2025)
Publié: (2025)
FDA warns against accidental overdose on fentanyl patches by children
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
FDA approves drug to treat neurologic manifestations of Hunter syndrome
Publié: (2026)
Publié: (2026)
Researchers find maternal use of ADHD stimulants safe during pregnancy
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
FDA requests removal of suicide warnings from two GLP‐1 labels
Publié: (2026)
Publié: (2026)
2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency
par: Alison Knopf
Publié: (2026)
par: Alison Knopf
Publié: (2026)
How to help young adults in the opioid and stimulant crisis
par: Alison Knopf
Publié: (2025)
par: Alison Knopf
Publié: (2025)
Experimental, but effective: Noninvasive brain stimulation for various disorders
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
CM management, best treatment for stimulant disorder, still on the ropes
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
NIDA calls for new pathway for cannabis research
par: Alison Knopf
Publié: (2025)
par: Alison Knopf
Publié: (2025)
Placebo response in TD treatment investigated
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
TMS‐connectivity response as predictor of TMS success
par: Alison Knopf
Publié: (2025)
par: Alison Knopf
Publié: (2025)
Contraindicated psychotropic medication use widespread
par: Alison Knopf
Publié: (2026)
par: Alison Knopf
Publié: (2026)
Parental substance use and violent behavior by their children
par: Alison Knopf
Publié: (2025)
par: Alison Knopf
Publié: (2025)
Prescribe for patients with opioid use disorder — with confidence
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
Externalizing problems and concurrent use of cannabis and tobacco
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
Prenatal use of benzodiazepines associated with preterm birth
par: Alison Knopf
Publié: (2026)
par: Alison Knopf
Publié: (2026)
Prenatal cannabis use linked to adverse birth outcomes
par: Alison Knopf
Publié: (2025)
par: Alison Knopf
Publié: (2025)
Substance use by teens stays low: MTF study
par: Alison Knopf
Publié: (2025)
par: Alison Knopf
Publié: (2025)
Substance use screening urged in EDs for youth in crisis
par: Alison Knopf
Publié: (2026)
par: Alison Knopf
Publié: (2026)
Screen time associated with substance use in young adolescents
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
Addictive screen use common in teens, linked to suicidal behaviors
par: Alison Knopf
Publié: (2025)
par: Alison Knopf
Publié: (2025)
Dopamine link between psychosis and cannabis use disorder unclear
par: Alison Knopf
Publié: (2025)
par: Alison Knopf
Publié: (2025)
Link between cannabis use and schizophrenia is likely causal, especially for teens
par: Alison Knopf
Publié: (2025)
par: Alison Knopf
Publié: (2025)
Literature review: Melatonin use by young children should be reduced or prevented
par: Alison Knopf
Publié: (2026)
par: Alison Knopf
Publié: (2026)
Researchers consider links between genetics and psychosis in teen use of psychedelics
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
Youth e‐cigarette use drops to recent low level: Good news
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
To find out how social media use affects teens, look at depression/anxiety
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
Documents similaires
-
Stimulant prescribing up among teens, but nonmedical use down
par: Alison Knopf
Publié: (2025) -
AACAP on advocating amidst stimulant shortage
par: Alison Knopf
Publié: (2024) -
Teens prescribed stimulants for ADHD not likely to have later drug misuse
par: Alison Knopf
Publié: (2024) -
FDA facing challenges: GAO
Publié: (2026) -
FDA lifts bans on fruit vapes
Publié: (2026)